Early therapy improves of chronic obstructive outcomes of exacerbations pulmonary disease

被引:490
作者
Wilkinson, TMA [1 ]
Donaldson, GC [1 ]
Hurst, JR [1 ]
Seemungal, TAR [1 ]
Wedzicha, JA [1 ]
机构
[1] St Bartholomews Hosp, Acad Unit Resp Med, St Bartholomews & Royal London Sch Med, London EC1A 7BE, England
关键词
chronic obstructive pulmonary disease; exacerbations; therapy;
D O I
10.1164/rccm.200310-1443OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves outcomes; however, responses to treatment are variable, and patients with COPD often delay presentation or fail to seek therapy. The impact on exacerbation outcomes, hospitalization, and health status of delaying or failing to seek treatment is poorly understood. We studied between 1996 and 2002 a cohort of 128 patients with COPD, mean (SD) FEV1 of 1.07 (0.43) L. Patients recorded respiratory symptoms daily and reported exacerbations to the outpatient-based study team or to their primary care physician; 1,099 exacerbations were recorded by the patients, of which 658 were reported to a physician. The time between exacerbation onset and treatment was a median (interquartile range) of 3.69 (2.0-5.57) days, and the exacerbation recovery time was 10.7 (7.0-14.0) days. Earlier treatment was associated with a faster recovery (regression coefficient 0.42 days/day delay) (confidence interval, 0.19-0.65; p < 0.001). Patients who reported a higher proportion of exacerbations for treatment had better health-related quality of life than those patients with more untreated exacerbations (rho = -0.22, p = 0.018). Failure to report exacerbations was associated with an increased risk of emergency hospitalization (rho = 0.21, p = 0.04). Patient recognition of exacerbation symptoms and prompt treatment improves exacerbation recovery, reduces risks of hospitalization, and is associated with a better health-related quality of life.
引用
收藏
页码:1298 / 1303
页数:6
相关论文
共 32 条
[1]   Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease [J].
Aaron, SD ;
Vandemheen, KL ;
Hebert, P ;
Dales, R ;
Stiell, IG ;
Ahuja, J ;
Dickinson, G ;
Brison, R ;
Rowe, BH ;
Dreyer, J ;
Yetisir, E ;
Cass, D ;
Wells, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2618-2625
[2]  
[Anonymous], DIS MGMT HLTH OUTCOM
[3]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[5]   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456
[6]   A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease [J].
Casaburi, R ;
Mahler, DA ;
Jones, PW ;
Wanner, A ;
San Pedro, G ;
ZuWallack, RL ;
Menjoge, SS ;
Serby, CW ;
Witek, T .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) :217-224
[7]   Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial [J].
Davies, L ;
Angus, RM ;
Calverley, PMA .
LANCET, 1999, 354 (9177) :456-460
[8]   Longitudinal changes in the nature, severity and frequency of COPD exacerbations [J].
Donaldson, GC ;
Seemungal, TAR ;
Patel, IS ;
Lloyd-Owen, SJ ;
Wilkinson, TMA ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :931-936
[9]   Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Seemungal, TAR ;
Bhowmik, A ;
Wedzicha, JA .
THORAX, 2002, 57 (10) :847-852
[10]   Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study) [J].
Garcia-Aymerich, J ;
Barreiro, E ;
Farrero, E ;
Marrades, RM ;
Morera, J ;
Antó, JM .
EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (06) :1037-1042